Mergers & Acquisitions - Pharmaceutical, Neurological

Filter

Popular Filters

1 to 25 of 50 results

Reckitt Benckiser to spin out pharma; GSK views Consumer options

Reckitt Benckiser to spin out pharma; GSK views Consumer options

28-07-2014

UK-based consumer goods giant Reckitt Benckiser plans to spin off its USA-based pharmaceutical business,…

FinancialGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserSuboxoneUK

Shire finally accepts AbbVie’s takeover offer

Shire finally accepts AbbVie’s takeover offer

18-07-2014

After a protracted and at times hostile courtship, Ireland-headquartered drugmaker Shire has finally…

AbbVieHumiraMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Shire confirms it has entered into talks with AbbVie

Shire confirms it has entered into talks with AbbVie

12-07-2014

Following reports by the Bloomberg news service, on Friday Ireland-based drugmaker Shire confirmed that…

AbbVieIrelandMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Kyowa Hakko to acquire Archimedes for £230 million

Kyowa Hakko to acquire Archimedes for £230 million

11-07-2014

Through its Scotland-based subsidiary ProStrakan Group, Japanese drugmaker Kyowa Hakko Kirin has entered…

ArchimedesArchimedes PharmaBusiness FinanceDriverHealth Medical PharmaKyowa Hakko KirinMergers & AcquisitionsNeurologicalNovo A/SOncologyPharmaceuticalPharmaceutical industryProStrakanUK

Lundbeck to complete Chelsea Thera acquisition today

Lundbeck to complete Chelsea Thera acquisition today

23-06-2014

Danish CNS specialist Lundbeck says that it has completed the tender offer to buy all of the outstanding…

Chelsea TherapeuticsLundbeckMergers & AcquisitionsNeurologicalNortheraPharmaceutical

Roche partners in new company for MS research

Roche partners in new company for MS research

23-06-2014

Swiss drug major Roche has entered into an exclusive partnership with Inception Sciences, a drug discovery…

Inception 5Inception SciencesMergers & AcquisitionsNeurologicalPharmaceuticalResearchRocheVersant Ventures

Cipla invests $1.5 million for 14.6% stake in USA’s Chase Pharma

14-05-2014

Indian drugmaker Cipla has said it will acquire a 14.6% stake in US-based Chase Pharmaceuticals for $1.5…

Chase PharmaceuticalsCiplaCPC 201Mergers & AcquisitionsNeurologicalPharmaceutical

Perrigo transfers ELND005 assets; buys OTC products

01-03-2014

Drugmaker Perrigo has entered into a series of agreements with existing collaboration partner, Transition…

ELND005Mergers & AcquisitionsNeurologicalPerrigoPharmaceuticalResearchTransition Therapeutics

NuPathe accepts Teva’s higher counter bid, rejecting Endo offer

21-01-2014

Israel-based Teva Pharmaceutical Industries seems set to bag ownership of US drugmaker NuPathe), which…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalTeva Pharmaceutical IndustriesZecuity

NuPathe rockets on news of takeover by Endo Health

NuPathe rockets on news of takeover by Endo Health

16-12-2013

In a third take-over deal announced this year, USA-based specialty health care company Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalZecuity

Torrent to acquire Indian branded formulations from Elder

13-12-2013

Torrent Pharmaceuticals saw its shares rise 7% to 349 rupees after it said it is acquiring the branded…

Asia-PacificElder PharmaceuticalsIndiaMergers & AcquisitionsNeurologicalPharmaceuticalTorrent PharmaceuticalsWomen's Health

Retrophin to acquire Kyalin Biosciences; in-licenses Syntocinon

13-12-2013

In a second takeover bid within a matter of months, USA-based Retrophin announced that it will acquire…

Kyalin BiosciencesLicensingMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalRetrophinSyntocinonWomen's Health

Sorrento Therapeutics gets clinical-stage chronic pain drug, along with Sherrington acquisition

16-10-2013

Sorrento Therapeutics has acquired Sherrington Pharmaceuticals. Financial terms of the deal were not…

CynviloqMergers & AcquisitionsNeurologicalPharmaceuticalresiniferatoxinSherrington PharmaceuticalsSorrento Therapeutics

Ipsen makes acquisition and signs R&D deal with Harvard

15-07-2013

French drugmaker Ipsen (Euronext: IPN) has acquired UK life sciences company Syntaxin for an upfront…

EuropeIpsenMergers & AcquisitionsNeurologicalPharmaceuticalSyntaxin

Biotie buys option to acquire Neurelis, and opportunity for epilepsy candidate

04-06-2013

Finland-based biotech firm Biotie Therapies (Nasdaq-OMX; BTH1V) says that it has obtained an exclusive…

BiotechnologyBiotie TherapiesMergers & AcquisitionsNeurelisNeurologicalNRL-1Pharmaceutical

Phytopharm views options, including merger, as Cogane fails

27-03-2013

UK-based Phytopharm (LSE: PYM: London Stock Exchange), ahead of its annual general meeting today (March…

CoganeMergers & AcquisitionsNeurologicalPharmaceuticalPhytopharmResearch

Elan sells its Tysabri rights to Biogen; posts 2012 financials

07-02-2013

Ireland-based drugmaker Elan Corp (NYSE: ELN) said yesterday that partner US biotech firm Biogen Idec…

Biogen IdecBiotechnologyElanFinancialMergers & AcquisitionsNeurologicalPharmaceuticalTysabri

Allergan to acquire MAP Pharmaceuticals in $958 million deal

24-01-2013

US drugmaker Allergan (NYSE: AGN) has entered into a definitive merger agreement to acquire 100% of the…

AllerganLevadexMAP PharmaceuticalsMergers & AcquisitionsNeurologicalPharmaceutical

Watson acquires Uteron Pharma; confirms Opana patent challenge

24-01-2013

US generic and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) says that it has completed the…

Endo PharmaceuticalsGenericsGrunenthalMergers & AcquisitionsNeurologicalNorth AmericaOpanaPatentsPharmaceuticalUteron PharmaWatson PharmaceuticalsWomen's Health

BioMarin acquires Zacharon Pharma for upfront $10 million

08-01-2013

US drugmaker BioMarin Pharmaceutical (Nasdaq: BMRN) says it has acquired Zacharon Pharmaceuticals, a…

BioMarin PharmaceuticalMergers & AcquisitionsNeurologicalPharmaceuticalZacharon Pharmaceutical

Illumina to buy Verinata; Rusnano et al invest in Marinus

08-01-2013

USA-based Illumina (Nasdaq: ILMN), recently the subject of a failed takeover bid by Swiss drug major…

Domain AssociatesFinancialganaxoloneIlluminaMarinus PharmaceuticalsMergers & AcquisitionsNeurologicalPharmaceuticalResearchRusNanoVerinata Health

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex

03-01-2013

Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

1 to 25 of 50 results

Back to top